These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3612415)

  • 21. [Progress in drug technology in the years 1968 and 1969].
    Chalabala M; Malý J; Burelová A
    Cesk Farm; 1970 Nov; 19(9):332-60. PubMed ID: 4926371
    [No Abstract]   [Full Text] [Related]  

  • 22. [Research on formulation process of Yigong capsule].
    Feng C; Cai YL; Ruan JL
    Zhong Yao Cai; 2008 Jan; 31(1):128-30. PubMed ID: 18589764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase transformation considerations during process development and manufacture of solid oral dosage forms.
    Zhang GG; Law D; Schmitt EA; Qiu Y
    Adv Drug Deliv Rev; 2004 Feb; 56(3):371-90. PubMed ID: 14962587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of mathematic methods for the determination of factors influencing the production of suppositories].
    Botschev B; Joakimov S; Trandafilov T; Welewa A
    Pharmazie; 1973 May; 28(5):337-8. PubMed ID: 4715055
    [No Abstract]   [Full Text] [Related]  

  • 25. [Influence of manufacturing conditions and physical properties of sulfonamide and palmitate suspensions of chloramphenicol on their stability and resorption].
    Moës A
    Mem Acad R Med Belg; 1969; 5(6):797-899. PubMed ID: 5360537
    [No Abstract]   [Full Text] [Related]  

  • 26. [Preparation of stable suspensions of sulfamide and chloramphenicol palmitate. Theoretical and practical study].
    Moës A
    Pharm Acta Helv; 1968 May; 43(5):290-320. PubMed ID: 5718861
    [No Abstract]   [Full Text] [Related]  

  • 27. Factorial designs in pharmaceutical preformulation studies. I. Evaluation of the application of factorial designs to a stability study of drugs in suspension form.
    Waltersson JO
    Acta Pharm Suec; 1986; 23(3):129-38. PubMed ID: 3766158
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies on the dispersion of drugs with special regard to suspension ointments. 4. The effectiveness of various pulverizing techniques for salicylic acid and prednisolone].
    Kögel J; Horsch W; Jäckel A
    Pharmazie; 1975 May; 30(5):311-6. PubMed ID: 1178742
    [No Abstract]   [Full Text] [Related]  

  • 29. Stability of fenbendazole suspensions for veterinary use. Correlation between zeta potential and sedimentation.
    Arias JL; López-Viota M; Clares B; Ruiz MA
    Eur J Pharm Sci; 2008 Aug; 34(4-5):257-62. PubMed ID: 18539013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Proposal for specifications concerning the study of dispersed systems (powders, suspensions...) very fine, extra-fine, ultrafine and micro-fine].
    Mayné F; Guyot JC; Traisnel M
    J Pharm Belg; 1976; 31(2):181-90. PubMed ID: 950583
    [No Abstract]   [Full Text] [Related]  

  • 31. Cohesive pharmaceutical powders.
    Pilpel N
    Adv Pharm Sci; 1971; 3():173-219. PubMed ID: 4947389
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacy compounding of an omeprazole suspension].
    Van Der Straeten F; Al-Afandi A; De Paepe K; Bovy J; Plaizier-Vercammen J
    J Pharm Belg; 2009 Jun; (2):54-63. PubMed ID: 19739529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Behavior of stabilized lotions under thermic stress].
    Rohdewald P
    Pharmazie; 1969 Dec; 24(12):773-5. PubMed ID: 5379022
    [No Abstract]   [Full Text] [Related]  

  • 34. Parenteral suspensions.
    Nash RA
    Bull Parenter Drug Assoc; 1972; 26(2):91-4. PubMed ID: 5012208
    [No Abstract]   [Full Text] [Related]  

  • 35. [A contribution on the preparation of tromethamol-(tris-buffer)-infusion solutions].
    Oberländer E; Fürtig W
    Pharm Prax; 1968; 1():2-5. PubMed ID: 5731387
    [No Abstract]   [Full Text] [Related]  

  • 36. Aspects of current parenteral formulation.
    Scheindlin S
    Bull Parenter Drug Assoc; 1970; 24(1):31-9. PubMed ID: 5415610
    [No Abstract]   [Full Text] [Related]  

  • 37. Supercritical fluid technology for enhanced drug delivery.
    Pathak P; Meziani MJ; Sun YP
    Expert Opin Drug Deliv; 2005 Jul; 2(4):747-61. PubMed ID: 16296799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of compounding and storage conditions on stability of pergolide mesylate.
    Davis JL; Kirk LM; Davidson GS; Papich MG
    J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.
    Fakes MG; Vakkalagadda BJ; Qian F; Desikan S; Gandhi RB; Lai C; Hsieh A; Franchini MK; Toale H; Brown J
    Int J Pharm; 2009 Mar; 370(1-2):167-74. PubMed ID: 19100319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preparation of pharmaceutical emulsions using the electric discharge technic].
    Issaev I; Minkov E; Najdenov S
    Pharmazie; 1972 Apr; 27(4):238-41. PubMed ID: 5053050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.